Behind every new cancer treatment and scientific breakthrough is a research team. However, because they spend most of their time in their labs, basic science researchers rarely get to meet the patients who benefit most from ...
Dec 14, 2020
1
2
Patients participating in The Leukemia & Lymphoma Society's (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard ...
Oct 27, 2020
0
33
A promising new biomarker that appears in patients before stomach cancer develops may help with early detection of the disease and improve patient response to therapy, according to findings in a study led by University of ...
Oct 20, 2020
0
27
(HealthDay)—Black and Hispanic patients with cancer used telehealth less often than White patients during the COVID-19 pandemic in New York City, according to a study presented at the ASCO Quality Care Symposium, held virtually ...
Oct 14, 2020
0
2
The effects of cancer treatment on a patient's body are easy to see, whether it is a lack of hair on their head, sores on their skin or a look of fatigue on their face. And while there has been a lot of discussion around ...
Oct 6, 2020
0
2
Selpercatinib (Retevmo), a drug targeted precisely against cancers driven by mutations or alterations in the gene RET, was effective in a clinical trial at shrinking tumors in patients with medullary thyroid cancer, with ...
Aug 26, 2020
0
36
Jefferson researchers developing a cancer vaccine to prevent recurrences of gastric, pancreatic, esophageal and colon cancers have added a component that would make the vaccine more effective. The change makes the vaccine ...
Aug 24, 2020
0
10
According to a study by The Wistar Institute, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells. These messages are packaged into particles called ...
Aug 10, 2020
0
119
Genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer in vivo, according to a new study published in the top-tier journal Cancer Research by investigators at the George ...
Aug 6, 2020
0
53
Today's Food and Drug Administration (FDA) approval of the first CAR T-cell therapy for mantle cell lymphoma (MCL) represents a key advance for patients with relapsed or treatment-resistant forms of the disease, say Dana-Farber ...
Jul 24, 2020
0
3
